The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
Study achieves primary endpoint of radiographic progression-free survival
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Subscribe To Our Newsletter & Stay Updated
